Company page

Samyang Biopharm Corporation

Samyang Biopharm Corporation, trading under the ticker 0120G0, is a public company based in Korea with a market capitalization of approximately 239.99 million. The company specializes in biopharmaceuticals, focusing on innovative therapies and healthcare solutions. As a key player in the biopharmaceutical industry, Samyang Biopharm is committed to advancing medical treatments and improving patient outcomes.